Terry and Helen Jones – A Lasting Legacy for Garvan

Terry and Helen Jones – A Lasting Legacy for Garvan
Partners For The Future
Terry and Helen Jones – A Lasting Legacy for Garvan

Mr and Mrs Terry and Helen Jones made the decision to include Garvan in their will after learning about Garvan’s research in 2013.

Mrs Jones, a breast cancer survivor, had just been diagnosed with the beginnings of an autoimmune disease. Curious about the research that Garvan was doing into autoimmune diseases, Mr and Mrs Jones spoke with Garvan’s Professor Antony Basten, a Senior Principal Research Fellow in Garvan’s Immunology Division.

The legacy that Mr and Mrs Jones will leave to Garvan will support numerous Garvan scientists to discover better ways to detect, treat and hopefully prevent autoimmune and immunological diseases.